Download Appendix A - Hazardous Agents.pdf

Contents : Environmental Health and Safety Office OUHSC/OU-Tulsa Laboratory Safety Manual APPENDIX A HAZARDOUS DRUGS AGENT Aldesleukin (rIL-2) Alemtuzumab Alitretinoin Altretamine Aminoglutethimide Amsacrine Anastrozole Arsenic Trioxide* Asparaginase/L-Asparaginase Azacytidine Azathioprime Bexarotene Bicalutamide Bleomycin/Bleomycin Sulfate Busulfan Capecitabine Carboplatin Carmustine (BCNU) CCNU Chlorambucil* Chloramphenicol Chlornaphazin Chlorotrianisene Chlorozotocin Cisplatin/Cis-Platin Cladribine (2-chlorode-oxyadenosine 2CdA) Cyclophosphamide* Cyclosporin Cytarabine (ara-C)/Cytosine Arabinoside Dacarbazine Dactinomycin (Actinomycin-D) Daunomycin* Daunorubicin/Daunorubicin Hydrochloride Daunorubicin (Liposomal) Denileukin Diftitox Diethylstilbesterol Docetaxel Doxorubicin Doxorubicin Hydrochloride Liposomal Injection Epinephrin (excluding Epinephrin salts)* Epirubicin/Epirubicin Hydrochloride Estradiol TRADE NAME Proleukin Campath Panretin Hexalen Arimidex Trisenox Elspar Azacytidine Azathioprine Targretin Casodex Blenoxane Myleran Xeloda Paraplatin BiCNU Belustine Leukeran Platinol Leustatin Cytoxan Neosar Cytosar-U DTIC DIC DTIC-Dome Cosmegen Cerubidine DaunoXome Ontak Taxotere Adriamycin Doxil Ellence *These agents are listed by the Environmental Protection Agency as hazardous wastes and must be disposed of as such Appendix A: Cytotoxic/Antineoplastic Agents 7/10 App. A-1 Environmental Health and Safety Office AGENT OUHSC/OU-Tulsa Laboratory Safety Manual TRADE NAME Estramustine Emcyt Ethinyl Estradiol Etoposide (VP-16-213) VePesid Exemestane Aromasin Floxuridine Fludarabine/Fludarabine Phosphate Fludara Fluorouracil/5-Fluorouracil Adrucil Flutamide Eulexin Fulvestrant Ganciclovir Gemcitabine Gemzar Gemtuzumab Ozogamicin Mylotarg Goserelin/Goserelin Acetate Zoladex Hydroxyurea Droxia Mylocel Ibritumomab Tiuetan Zevalin Idarubicin Idamycin Ifosfamide Ifex Imatinib Mesylate Gleevec Interferon-A/Interferon Alfa (2a 2b) Roferon-A Intron-A Interleukin-2 (IL-2) Irinotecan (CPT-11) Camposar Isotretrinoin Letrozole Femara Leuprolide/Leuprolide Acetate Lupron Lupron Depot Levamisole Ergamisol Lomustine (CCNU) CeeNu Mechlorethamine (Nitrogen Mustard) Mustargen Mechlorethamine Hydrochloride Medroxyprogesterone/Medroxyprogesterone Acetate Provera Megestrol/Megestrol Acetate Megace Melphalan* Alkeran Mercaptopurine (6-MP) Purinethol Methotrexate (MTX) Mexate Folex Methyl-CCNU Semustine Mithramycin Mithracin Mitomycin Mitomycin C* Mutamycin Mitotane Mitoxantrone Novantrone Myleran Nafarelin Nicotine* Nilutamide NIlandron Nitrogen Mustard Mustargen Nitroglycerin* *These agents are listed by the Environmental Protection Agency as hazardous wastes and must be disposed of as such Appendix A: Cytotoxic/Antineoplastic Agents 7/10 App. A-2 Environmental Health and Safety Office AGENT Oprelvekin Oxaliplatin Paclitaxel Pegaspargase Pentostatin (2-deoxycoformycin DCF) Phentermine* Physostigmine* Physostigmine salicylate* Pipobroman Plicamycin Procarbazine/Procarbazine Hydrochloride Ribavirin Rituximab Streptozocin (Streptozoticin)* Tamoxifen/Tamoxifen Citrate Temozolomide Teniposide Teosulfan Testolactone Thioguanine Thiotepa Topotecan Toremifene/Toremifene Citrate Trastuzumab Tretinoin (ATRA) Triethylene Thiophosphoramide Triptorelin Pamoate Uracil Mustard* Valrubicin Vidarabine Vinblastine/Vinblastine Sulfate Vincristine/Vincristine Sulfate Vindesine Vinorelbine/Vinorelbine Tartrate VM-26 Warfarin* Zidovudine OUHSC/OU-Tulsa Laboratory Safety Manual TRADE NAME Neumega Taxol Nipent Matulane Rituxan Zanosar Nolvadex Temodar Vumon Thioplex Hycamtin Fareston Herceptin Vesanoid Thiotepa Trelstar Depot Uramustine Velban Oncovin Navelbine Retrovir *These agents are listed by the Environmental Protection Agency as hazardous wastes and must be disposed of as such Sources: American Hospital Formulary Service Drug Information 1995 American Hospital Formulary Service Drug Information 2002 Occupational Safety and Health Administration (OSHA) Instruction PUB 8-1.1 Appendix A Work Practice Guidelines for Personnel Dealing with Cytotoxic (Antineoplastic) Drugs January 29 1986 OSHA Instruction CPL 2-2.20B CH-4 Chapter 21 Controlling Occupational Exposure to Hazardous Drugs April 14 1995 OSHA Technical Manual Section VI Chapter 2 Appendix VI:2-1 Some Common Drugs that are Considered Hazardous Environmental Protection Agency Regulation 40 CFR 261.33 Oklahoma Department of Environmental Quality Instructions for Disposal of Antineoplastic (Chemotherapy) Agents at Permitted Biomedical Waste Incinerators Appendix A: Cytotoxic/Antineoplastic Agents 7/10 App. A-3 Environmental Health and Safety Office OUHSC/OU-Tulsa Laboratory Safety Manual Adams Val R. Guide to Cancer Chemotherapeutic Regimens Pharmacy Practice News October 2002 Supplement pp. 29-46. Adams Val R. Guide for the Administration and Use of Cancer Chemotherapeutic Agents 2003 Oncology Special Edition Vol 6 2003 pp. 123-

INFO HASH : f7264badd5475a0b80c71b5de56703eb3e53dce4

Download now

File Size: 14.4 kb